Controlled release microparticles as a single dose diphtheria toxoid vaccine: immunogenicity in small animal models.

No abstract is available for this paper.

• Publication year

  1998

• Venue

  Vaccine

• Publication date

  1998-02-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/S0264-410X(97)80912-7PMID 9607054
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Controlled release microparticles as a single dose hepatitis B vaccine: evaluation of immunogenicity in mice.

  1997cited by this paper
• The encapsulation of a model protein in poly (D, L lactide-co-glycolide) microparticles of various sizes: an evaluation of process reproducibility.

  1997cited by this paper
• Poly (D,L-Lactide) glycolide polymer microsphere entrapped tetanus toxoid: safety evaluation in Wistar rats

  1996cited by this paper
• Intranasal stimulation of long-lasting immunity against aerosol ricin challenge with ricin toxoid vaccine encapsulated in polymeric microspheres.

  1996cited by this paper
• Embryotoxicity and teratogenicity studies of poly (DL-Lactide-co-Glycolide) microspheres incorporated tetanus toxoid in Wistar rats

  1996cited by this paper
• Setting priorities for the Children's Vaccine Initiative: a cost-effectiveness approach.

  1995cited by this paper
• Biodegradable Delivery System for a Birth Control Vaccine: Immunogenicity Studies in Rats and Monkeys

  1995cited by this paper
• A single administration of tetanus toxoid in biodegradable microspheres elicits T cell and antibody responses similar or superior to those obtained with aluminum hydroxide.

  1995cited by this paper
• Mechanisms of moisture-induced aggregation of tetanus toxoid

  1995cited by this paper
• Stabilization of tetanus and diphtheria toxoids against moisture-induced aggregation.

  1995cited by this paper
• Acellular pertussis vaccines in infants: evaluation of single component and two-component products.

  1994cited by this paper
• Biodegradable microspheres as controlled-release tetanus toxoid delivery systems.

  1994cited by this paper
• The Preparation and Characterization of Poly(lactide-co-glycolide) Microparticles. II. The Entrapment of a Model Protein Using a (Water-in-Oil)-in-Water Emulsion Solvent Evaporation Technique

  1993cited by this paper
• Future approaches to vaccine development: single-dose vaccines using controlled-release delivery systems.

  1993cited by this paper
• In vivo biocompatibility studies of medisorb® 65/35 D,L-lactide/glycolide copolymer microspheres

  1993cited by this paper
• Absence of protective immunity against diphtheria in a large proportion of young adults.

  1993cited by this paper
• Immunogenicity studies on diphtheria toxoid loaded biodegradable microspheres

  1992cited by this paper
• Controlled-release vaccines--biodegradable polylactide/polyglycolide (PL/PG) microspheres as antigen vehicles.

  1992cited by this paper
• Impact of Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine on responses to concurrently administered diphtheria-tetanus-pertussis vaccine.

  1992cited by this paper
• The clinical and immunologic response of Chilean infants to Haemophilus influenzae type b polysaccharide-tetanus protein conjugate vaccine coadministered in the same syringe with diphtheria-tetanus toxoids-pertussis vaccine at two, four and six months of age.

  1991cited by this paper
• Biodegradable microparticles as controlled release antigen delivery systems.

  1991cited by this paper
• Controlled Delivery of Diphtheria Toxoid Using Biodegradable Poly(D,L-Lactide) Microcapsules

  1991cited by this paper
• Biodegradable microspheres as a vaccine delivery system.

  1991cited by this paper
• The preparation and characterisation of poly(lactide-co-glycolide) microparticles. I: Oil-in-water emulsion solvent evaporation

  1991cited by this paper
• Intestinal translocation of particulates — implications for drug and antigen delivery

  1990cited by this paper
• Nafarelin controlled release injectable: theoretical clinical plasma profiles from multiple dosing and from mixtures of microspheres containing 2 per cent, 4 per cent and 7 per cent nafarelin.

  1990cited by this paper
• Novel drug delivery and its therapeutic application

  1989cited by this paper
• Effect of the size and surface charge of polymer microspheres on their phagocytosis by macrophage.

  1988cited by this paper
• Delivery Systems for Peptide Drugs

  1986cited by this paper
• Biodegradable Polymers for Sustained Release of Polypeptides

  1986cited by this paper
• The titration of tetanus antitoxin IV. Studies on the sensitivity and reproducibility of the toxin neutralization test.

  1985cited by this paper
• Aliphatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo.

  1981cited by this paper
• DIPHTHERIA TOXOID AS AN IMMUNIZING AGENT.

  1927cited by this paper
• Diphtheria Toxoid as an Immunising Agent.

  1923cited by this paper

• Injectable controlled-release systems for the prevention and treatment of infectious diseases.

  2023cites this paper
• Engineered drug delivery devices to address Global Health challenges

  2021cites this paper
• Polyester as Antigen Carrier toward Particulate Vaccines.

  2019cites this paper
• Techniques Employed in Production of Traditional Vaccines Commonly Used by Military Forces: A Review

  2019cites this paper
• Virus-Like Particle, Liposome, and Polymeric Particle-Based Vaccines against HIV-1

  2018cites this paper
• Immunogenicity of pulsatile-release PLGA microspheres for single-injection vaccination

  2017cites this paper
• Macromolecular systems for vaccine delivery.

  2016cites this paper
• Development of a self-emulsification process for emulsion adjuvants and the effect of droplet size on vaccine response

  2016cites this paper
• The preparation and characterization of PLG nanoparticles with an entrapped synthetic TLR7 agonist and their preclinical evaluation as adjuvant for an adsorbed DTaP vaccine.

  2016cites this paper
• Single-injection vaccines: Progress, challenges, and opportunities.

  2015cites this paper
• Next generation vaccines: single‐dose encapsulated vaccines for improved global immunisation coverage and efficacy

  2015cites this paper
• The impact of size on particulate vaccine adjuvants.

  2014cites this paper
• Development and evaluation of chitosan microspheres for tetanus, diphtheria and divalent vaccines: a comparative study of subcutaneous and intranasal administration in mice

  2013cites this paper
• Nanotechnology in Vaccine Development

  2012cites this paper
• The long-term potential of biodegradable poly(lactideco-glycolide) microparticles as the next-generation vaccine adjuvant

  2011cites this paper
• Pathogen-associated molecular patterns on biomaterials: a paradigm for engineering new vaccines.

  2011cites this paper
• Single shot tetanus vaccine manufactured by a supercritical fluid encapsulation technology.

  2011cites this paper
• Studies on the development of a Bacillus endospore-based microparticle vaccine platform

  2011cites this paper
• A novel vaccine delivery system: Biodegradable nanoparticles in thermosensitive hydrogel

  2011cites this paper
• Polymeric lamellar substrate particles as carrier adjuvant for recombinant hepatitis B surface antigen vaccine.

  2009cites this paper
• Role of alum in improving the immunogenicity of biodegradable polymer particle entrapped antigens.

  2009cites this paper
• Design opportunities for actively targeted nanoparticle vaccines.

  2008cites this paper
• Compositions et procédés destinés à moduler des réponses immunes

  2007cites this paper
• Preparing and evaluating delivery systems for proteins.

  2006cites this paper
• Effect of radio-opaque filler on biodegradable stent properties.

  2006cites this paper
• Microparticle-based technologies for vaccines.

  2006cites this paper
• Microparticles as vaccine delivery systems

  2006cites this paper
• Starch microparticles as vaccine adjuvant

  2005cites this paper
• Mucosal and Systemic Adjuvant Effects of Cholera Toxin and Cry1Ac Protoxin on the Specific Antibody Response to HIV-1 C4/V3 Peptides Are Different and Depend on the Antigen Co-administered

  2005cites this paper
• Exploiting receptor biology for oral vaccination with biodegradable particulates.

  2005cites this paper
• Biodegradable poly(lactic-co-glycolic acid) microparticles for injectable delivery of vaccine antigens.

  2005cites this paper
• The immunogenicity-enhancing effect of emulsion vaccine adjuvants is independent of the dispersion type and antigen release rate--a revisit of the role of the hydrophile-lipophile balance (HLB) value.

  2005cites this paper
• A comparative study of different presentation strategies for an HIV peptide immunogen.

  2004cites this paper
• Novel biocompatible anionic polymeric microspheres for the delivery of the HIV-1 Tat protein for vaccine application.

  2004cites this paper
• Development of a new oral vaccine against diphtheria and the study of its immunogenicity in mouse and man.

  2004cites this paper
• Improved Antigen Delivery Systems with PLGA Microsphere for a Single-Step Immunization

  2004cites this paper
• Antigen-specific IgA and IgG responses in calves inoculated intranasally with ovalbumin encapsulated in poly(DL-lactide-co-glycolide) microspheres.

  2003cites this paper
• Potentiation of Immune Response from Polymer-Entrapped Antigen: Toward Development of Single Dose Tetanus Toxoid Vaccine

  2003influential citation
• An experimental divalent vaccine based on biodegradable microspheres induces protective immunity against tetanus and diphtheria.

  2003cites this paper
• On Technological and Immunological Benefits of Multivalent Single-Injection Microsphere Vaccines

  2002cites this paper
• Immunization of rabbits against a bacterial pathogen with an alginate microparticle vaccine.

  2002cites this paper
• Immunosterilisation affecting the functional level of reproductive hormones.

  2002cites this paper
• Continuous antigen delivery from controlled release implants induces significant and anamnestic immune responses.

  2002cites this paper
• Collagen minipellet as a controlled release delivery system for tetanus and diphtheria toxoid.

  2001cites this paper
• Towards clinical testing of a single-administration tetanus vaccine based on PLA/PLGA microspheres.

  2000cites this paper
• Revisiting PLA/PLGA microspheres: an analysis of their potential in parenteral vaccination.

  2000cites this paper
• Peptide synthesis containing a B-cell and a T-cell epitope on dextran beads and evaluation of humoral response against bead-peptide construct

  2000cites this paper
• Comparison of in vitro and in vivo methods to study stability of PLGA microencapsulated tetanus toxoid vaccines.

  2000cites this paper
• Formulation of poly(D,L-lactic-co-glycolic acid) microparticles for rapid plasmid DNA delivery.

  2000cites this paper
• Maintaining and enhancing vaccine immunogenicity.

  1999cites this paper
• Potential of polymeric lamellar substrate particles (PLSP) as adjuvants for vaccines.

  1999cites this paper
• Recent advances in immunological adjuvants: the development of particulate antigen delivery systems.

  1998cites this paper
• Poly(lactide-co-glycolide) microparticles for the development of single-dose controlled-release vaccines.

  1998cites this paper